
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
Access through your institution Buy or subscribe Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases with a similar incidence to acute myeloid leukaemia (AML), but much
less is known about the genetic basis of MDS. Discriminating between MDS and AML is based largely on cytomorphological analysis, and a myeloblast count of ≥20% is confirmation of an AML
diagnosis. Although a minority of patients with MDS are cured with haematopoietic stem-cell transplanation, most existing treatments are not curative. Thus, a better understanding of the
genetic basis of MDS to AML progression would allow development of more-effective treatments. Two studies published in the _New England Journal of Medicine_ have now shed light on the
genetics of AML. Using whole-genome sequencing, one study showed the importance of the diversity of clonal evolution of MDS and AML, while the other using mutational analysis demonstrated
that mutations in _DNMT3A_, _MLL_ and _NPM1_ identify patients with AML who have an improved outcome in response to high-dose induction chemotherapy. This is a preview of subscription
content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue
Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL
ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support ORIGINAL RESEARCH PAPERS * Walter, M. J. _ et al_. Clonal architecture of
secondary acute myeloid leukemia. _N. Engl. J. Med._ 366, 1090–1098 (2012) Article CAS Google Scholar * Patel, J. P. _ et al_. Prognsotic relvance of integrated genetic profiling in acute
myeloid leukemia. _N. Engl. J. Med._ 366, 1079–1089 (2012) Article CAS Google Scholar Download references Authors * Lisa Hutchinson View author publications You can also search for this
author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Hutchinson, L. Turning the clock back on clonal evolution. _Nat Rev Clin
Oncol_ 9, 245 (2012). https://doi.org/10.1038/nrclinonc.2012.50 Download citation * Published: 03 April 2012 * Issue Date: May 2012 * DOI: https://doi.org/10.1038/nrclinonc.2012.50 SHARE
THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to
clipboard Provided by the Springer Nature SharedIt content-sharing initiative